Logo image of EKOP.BR

EKOPAK NV (EKOP.BR) Stock Fundamental Analysis

EBR:EKOP - Euronext Brussels - BE0974380124 - Common Stock - Currency: EUR

6.52  -0.14 (-2.1%)

Fundamental Rating

3

Taking everything into account, EKOP scores 3 out of 10 in our fundamental rating. EKOP was compared to 44 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of EKOP have multiple concerns. EKOP is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EKOP had negative earnings in the past year.
EKOP had a positive operating cash flow in the past year.
EKOP had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: EKOP reported negative operating cash flow in multiple years.
EKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFEKOP.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.20%, EKOP is doing worse than 68.18% of the companies in the same industry.
With a Return On Equity value of -9.12%, EKOP is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.2%
ROE -9.12%
ROIC N/A
ROA(3y)-1.96%
ROA(5y)-0.86%
ROE(3y)-3.48%
ROE(5y)-1.29%
ROIC(3y)N/A
ROIC(5y)N/A
EKOP.BR Yearly ROA, ROE, ROICEKOP.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 100 150 200 250

1.3 Margins

With a Gross Margin value of 31.40%, EKOP is not doing good in the industry: 61.36% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of EKOP has declined.
The Profit Margin and Operating Margin are not available for EKOP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.58%
GM growth 5Y-5.29%
EKOP.BR Yearly Profit, Operating, Gross MarginsEKOP.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 -10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

EKOP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EKOP remains at a similar level compared to 1 year ago.
EKOP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EKOP has a worse debt to assets ratio.
EKOP.BR Yearly Shares OutstandingEKOP.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M
EKOP.BR Yearly Total Debt VS Total AssetsEKOP.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 0.85, we must say that EKOP is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.85, EKOP is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.95 indicates that EKOP is somewhat dependend on debt financing.
EKOP has a Debt to Equity ratio of 0.95. This is comparable to the rest of the industry: EKOP outperforms 40.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Altman-Z 0.85
ROIC/WACCN/A
WACC6.57%
EKOP.BR Yearly LT Debt VS Equity VS FCFEKOP.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

EKOP has a Current Ratio of 1.18. This is a normal value and indicates that EKOP is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.18, EKOP perfoms like the industry average, outperforming 47.73% of the companies in the same industry.
A Quick Ratio of 0.96 indicates that EKOP may have some problems paying its short term obligations.
EKOP has a Quick ratio (0.96) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.96
EKOP.BR Yearly Current Assets VS Current LiabilitesEKOP.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for EKOP have decreased strongly by -310.53% in the last year.
EKOP shows a strong growth in Revenue. In the last year, the Revenue has grown by 121.96%.
EKOP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.37% yearly.
EPS 1Y (TTM)-310.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-828.57%
Revenue 1Y (TTM)121.96%
Revenue growth 3Y56.07%
Revenue growth 5Y40.37%
Sales Q2Q%128.57%

3.2 Future

EKOP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 75.07% yearly.
Based on estimates for the next years, EKOP will show a very strong growth in Revenue. The Revenue will grow by 27.32% on average per year.
EPS Next Y-206.25%
EPS Next 2Y-15.47%
EPS Next 3Y31.04%
EPS Next 5Y75.07%
Revenue Next Year49.82%
Revenue Next 2Y42.65%
Revenue Next 3Y34.3%
Revenue Next 5Y27.32%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
EKOP.BR Yearly Revenue VS EstimatesEKOP.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
EKOP.BR Yearly EPS VS EstimatesEKOP.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2028 0 0.5 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EKOP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EKOP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EKOP.BR Price Earnings VS Forward Price EarningsEKOP.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EKOP is valued a bit more expensive than the industry average as 68.18% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.27
EKOP.BR Per share dataEKOP.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as EKOP's earnings are expected to grow with 31.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.47%
EPS Next 3Y31.04%

More info and screens

0

5. Dividend

5.1 Amount

EKOP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EKOPAK NV

EBR:EKOP (5/6/2025, 1:36:50 PM)

6.52

-0.14 (-2.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-11 2025-04-11/amc
Earnings (Next)N/A N/A
Inst Owners3.02%
Inst Owner ChangeN/A
Ins Owners79.19%
Ins Owner ChangeN/A
Market Cap96.63M
Analysts77.78
Price Target5.46 (-16.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-70.28%
PT rev (3m)-77.23%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-133.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.78
P/FCF N/A
P/OCF 45.73
P/B 1.86
P/tB 182.66
EV/EBITDA 39.27
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-1.95
FCFYN/A
OCF(TTM)0.14
OCFY2.19%
SpS3.67
BVpS3.5
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.2%
ROE -9.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.4%
FCFM N/A
ROA(3y)-1.96%
ROA(5y)-0.86%
ROE(3y)-3.48%
ROE(5y)-1.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.58%
GM growth 5Y-5.29%
F-Score3
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Debt/EBITDA 12.77
Cap/Depr 364.09%
Cap/Sales 57.04%
Interest Coverage N/A
Cash Conversion 54.83%
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 0.96
Altman-Z 0.85
F-Score3
WACC6.57%
ROIC/WACCN/A
Cap/Depr(3y)612.46%
Cap/Depr(5y)506.59%
Cap/Sales(3y)62.12%
Cap/Sales(5y)44.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-310.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-828.57%
EPS Next Y-206.25%
EPS Next 2Y-15.47%
EPS Next 3Y31.04%
EPS Next 5Y75.07%
Revenue 1Y (TTM)121.96%
Revenue growth 3Y56.07%
Revenue growth 5Y40.37%
Sales Q2Q%128.57%
Revenue Next Year49.82%
Revenue Next 2Y42.65%
Revenue Next 3Y34.3%
Revenue Next 5Y27.32%
EBIT growth 1Y-231.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year766.67%
EBIT Next 3Y202.45%
EBIT Next 5Y127.85%
FCF growth 1Y-123.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.32%
OCF growth 3YN/A
OCF growth 5Y88.75%